Obstructive Sleep Apnea News and Research

RSS

Obstructive sleep apnea (OSA) is a major heath problem. In the United States, at least 17 million people have moderate to severe OSA, which is characterized by heavy snoring, airway blockage and frequent awakenings during sleep.

Avanafil phase 3 trial in ED following radical prostatectomy meets primary endpoints

VIVUS, Inc. today announced positive results from a phase 3, placebo-controlled clinical trial of the investigational drug avanafil for the treatment of erectile dysfunction in patients following a radical prostatectomy.

25 May 2011

Intermittent hypoxia enhances cancer growth in mouse model of obstructive sleep apnea

A new study links the intermittent interruption of breathing that occurs in patients with obstructive sleep apnea to enhanced proliferation of melanoma cancer cells and increased tumor growth in mice, according to researchers in Spain.

18 May 2011

Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints

VIVUS, Inc. today announced that positive results from a pivotal phase 3 open-label clinical trial evaluating long-term safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction were presented at the 2011 Annual Meeting of the American Urological Association in Washington, D.C.

18 May 2011

Adenotonsillectomy prevents high blood pressure and heart damage in children with OSA

Removing enlarged tonsils and adenoids may help prevent high blood pressure and heart damage in children who suffer from obstructive sleep apnea, according to a study conducted at Cincinnati Children's Hospital Medical Center.

17 May 2011

Continuous positive airway pressure can increase alertness, improve quality of life in OSA patients

Continuous positive airway pressure, or CPAP, can increase alertness and even improve quality of life for sufferers of obstructive sleep apnea, even if their symptoms are minimal, according to a study conducted by researchers in Europe.

16 May 2011

Continuous positive airway pressure reduces cardiovascular mortality in elderly OSA patients

Continuous positive airway pressure (CPAP) effectively decreases the risk of cardiovascular death in elderly patients who suffer from obstructive sleep apnea (OSA), according to a study conducted by researchers in Spain.

16 May 2011

ImThera Medical concludes Phase I and II protocols for aura6000 European Pilot study in OSA

ImThera Medical, Inc. today announced that it has concluded its Phase I and Phase II protocols for the European Pilot study of the aura6000, a neurostimulation device for treating Obstructive Sleep Apnea (OSA). Clinical trial results from the study will be announced at the American Thoracic Society's International Conference on May 16, 2011 in Denver, CO.

9 May 2011

Rotech Healthcare first quarter adjusted EBITDA increases 13% to $28.3 million

Rotech Healthcare Inc. today announced financial results for the first quarter ended March 31, 2011.

7 May 2011

Poor sleep may contribute to high insulin resistance in diabetic people

In the largest study of it kind to establish a link between sleep and diabetes, researchers found that people with diabetes who sleep poorly have higher insulin resistance, and a harder time controlling the disease.

3 May 2011

The Lancet publishes VIVUS 56-week QNEXA study results in obesity

VIVUS, Inc. today announced that detailed results from the 56-week CONQUER study were published in The Lancet evaluating the efficacy and safety of investigational drug QNEXA in 2,487 patients across 93 sites in the US.

11 Apr 2011

Treating obstructive sleep apnea in stroke patients improves recovery from stroke

A new study shows that patients in stroke rehabilitation treated for their co-existing obstructive sleep apnea (OSA) recovered better from stroke than those whose OSA was not treated.

6 Apr 2011

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

A study in the April 1 issue of the journal SLEEP suggests that the risk of death is more than two times higher in older adults who have sleep apnea and report struggling with excessive daytime sleepiness.

1 Apr 2011

Graymark Healthcare 2010 net revenues increase 30% to $22.8 million

Graymark Healthcare, Inc., the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), reported financial results for the fiscal year ended December 31, 2010.

28 Mar 2011

Rotech closes private offering of $290M in Senior Notes due 2018

Rotech Healthcare Inc. announced the closing of its previously announced offering of $290 million in aggregate principal amount of Senior Second Lien Notes due 2018.

19 Mar 2011

Patients with BPE may have Obstructive Sleep Apnea

Ben-Gurion University of the Negev researchers have shown that a significant number of patients with benign prostate enlargement may have Obstructive Sleep Apnea, which may be the reason for their night awakenings and urination.

16 Mar 2011

Bariatric surgery can lead to long-term weight loss, reduce cardiac risk factors in obese adults

Bariatric surgery can result in long-term weight loss and significant reductions in cardiac and other risk factors for some severely obese adults, according to a scientific statement from the American Heart Association.

15 Mar 2011

ATS releases new report recommending research priorities in OSA treatment

The American Thoracic Society has released a new official report recommending research priorities in incorporating ambulatory management of adults with obstructive sleep apnea into healthcare systems.

4 Mar 2011

Ventus Medical's Provent Sleep Apnea Therapy granted CE Mark

Ventus Medical, Inc. a privately-held medical device company dedicated to providing novel products to treat sleep-disordered breathing, today announced that it has received CE Mark for its Provent® Sleep Apnea Therapy.

3 Mar 2011

Alternative intraoral appliance to treat obstructive sleep apnea

AZ-TMJ is once again leading the way in innovative and effective treatments for patients with obstructive sleep apnea (OSA). Approximately one in five adults have at least mild sleep apnea, and one in 15 are classified as moderate sleep apnea sufferers. Sleep apnea is a disorder where a person's ability to breathe is impaired, resulting in a restless sleep and oftentimes snoring.